VRCA FY 2020 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$229,000

Operating Income

-$40M

Net Income

-$45M

EPS (Diluted)

$-17.08

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$74M

Total Liabilities

$41M

Stockholders' Equity

$33M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$229,000	-$257,199	+11.0%
Operating Income	-$40M	-$30M	-33.6%
Net Income	-$45M	-$28M	-61.3%